BioPharmX Corporation (BPMX:NYSEMKT) shot up at $0.65, representing a gain of 78.4%. On Fri 28 Feb 20, BPMX:NYSEMKT hit a New 2-Week Intraday Low of $0.36. From Fri 07 Feb 20, the stock recorded 28.57% Up Days and 20.00% Green Days
The stock spiked on Mon 27 Jan 20 at $1.05 with a volume of 6M+, and its share price has been moving sideways in recent weeks.
About BioPharmX Corporation (BPMX:NYSEMKT)
BioPharmX Corp is a specialty pharmaceutical company. It is engaged in utilizing its proprietary drug delivery technologies to develop & commercialize novel prescription & over-the-counter, products that address markets in women's health & dermatology.
Top 10 Gainers:
- Heat Biologics, Inc. (HTBX:NASDAQ), 142.42%
- Novan, Inc. (NOVN:NASDAQ), 112.51%
- China Pharma Holdings, Inc. (CPHI:NYSEMKT), 100%
- BioPharmX Corporation (BPMX:NYSEMKT), 78.38%
- Karyopharm Therapeutics Inc. (KPTI:NASDAQ), 69.65%
- Daxor Corporation (DXR:NYSEMKT), 65.7%
- Forty Seven, Inc. (FTSV:NASDAQ), 61.91%
- Titan Pharmaceuticals, Inc. (TTNP:NASDAQ), 55.83%
- NuCana plc (NCNA:NASDAQ), 45.74%
- InflaRx N.V. (IFRX:NASDAQ), 43.4%